Evogene Ltd.
Evogene Ltd. (EVGN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
evgn · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$2.15
Consensus
$2.15
+268.8% upside
Low
$2.15
Median: $2.15 · Last Close: $0.58
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.55 | ↓ 5.00% |
1-day model range: $0.54–$0.56. Peak: $0.56 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · EVGN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-05-22 | Lake Street | Maintains | Buy→Buy |
| 2024-08-23 | Lake Street | Maintains | Buy→Buy |
| 2023-08-18 | Lake Street | Maintains | Buy→Buy |
| 2023-07-21 | Roth MKM | Maintains | Buy→Buy |
| 2022-09-12 | Aegis Capital | Maintains | Buy→Buy |
| 2022-09-02 | Roth MKM | Maintains | Buy→Buy |
| 2014-11-12 | Credit Suisse | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Evogene Ltd. (EVGN) stock. Of the recent 7 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover EVGN.
Analyst Recommendation Trends
EVGN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↓ 70.0% YoY
Revenue Next Year
$3M
↑ 75.2% YoY
EPS This Year
$-1.70
EPS Next Year
$-0.80
↓ 52.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast EVGN EPS of $-1.70 for the current fiscal year, based on estimates from 1 analysts. The EVGN revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The EVGN stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EVGN price target is $2.15 (+268.8% upside), with an analyst consensus of Buy.
The EVGN short-term stock prediction for tomorrow is $0.55 (-5.00%).
Evogene Ltd. trades on NASDAQ under the ticker EVGN. The EVGN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
EVGN forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month EVGN price target is $2.15, with a high forecast of $2.15 and a low of $2.15. The median price target is shown in the chart above when available. This implies +268.8% potential upside from the current price of $0.58.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.